Back to Studies

P1083 / Kaletra/Aluvia PK study

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Study Status

Concluded

DAIDS Number

10787

IND Number

108,894

Clinical Trials Link

Study Chair

NICHD Medical Officer

Clinical Research Manager

DAIDS Clinical Representative

Drug Co. Representative

ICAB Representative

Laboratory Specialist

Laboratory Technologist

Medical Officer

Senior Statistician

Statistician

Virologist

Westat Representative

Abstracts

Population Pharmacokinetics of Lopinavir with WHO Weight Band Dosing - IMPAACT P1083

Conference

ICAAC 2015

Study

P1083

Authors

Joseph Chen, Jorge Pinto, Mark Mirochnick, Meredith Warshaw, Bonnie Zimmer, Vincent Carey, Betsy Smith, George Siberry, Tim R. Cressey, Stephen A. Spector , Edmund V. Capparelli for the IMPAACT P1083 Team

Pharmacokinetics of Lopinavir/ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines: Interim Results from IMPAACT P1083

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1083